AGIO - Agios Pharmaceuticals Inc. (AGIO) Q1 2024 Earnings Call Transcript
2024-05-02 16:32:14 ET
Agios Pharmaceuticals, Inc. (AGIO)
Q1 2024 Earnings Conference Call
May 2, 2024 08:00 ET
Company Participants
Chris Taylor - Vice President, Investor Relations and Corporate Communications
Brian Goff - Chief Executive Officer
Sarah Gheuens - Chief Medical Officer and Head, R&D
Tsveta Milanova - Chief Commercial Officer
Cecilia Jones - Chief Financial Officer
Conference Call Participants
Gregory Renza - RBC Capital Markets
Divya Rao - TD Cowen
Eric Schmidt - Cantor
Alec Stranahan - Bank of America
Tessa Romero - JPMorgan
Danielle Brill - Raymond James
Presentation
Operator
Good morning, and welcome to Agios’ First Quarter 2024 Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded at Agios’ request. I would now like to turn the call over to Chris Taylor, Vice President, Investor Relations and Corporate Communications for Agios. Please begin.
Chris Taylor
Thank you, operator. Good morning, everyone, and welcome to Agios’ conference call and webcast to discuss first quarter 2024 financial results and recent business highlights. You can access slides for today’s call by going to the Investors section of our website, agios.com.
On today’s call, I’m joined by our Chief Executive Officer, Brian Goff; Dr. Sarah Gheuens, Chief Medical Officer and Head of R&D; Tsveta Milanova, our Chief Commercial Officer; and Cecilia Jones, Chief Financial Officer.
Before we get started, I would like to remind everyone that some of the statements we make on this call will include forward-looking statements. Actual results and events could differ materially from those expressed or implied by any forward-looking statements as a result of various risks, uncertainties and other factors, including those set forth in our most recent filings with the SEC and any other future filings that we may make with the SEC....
Agios Pharmaceuticals, Inc. (AGIO) Q1 2024 Earnings Call Transcript